重新绘制肠道地图:在炎症性肠道疾病中,益生菌对微生物群调节的方法不断发展
Premal Vaghela1, Bhavarth Dave1, Akshada Dabhade1
1Department of Pharmacology, L. M. College of Pharmacy, Opp. Gujarat University, Navrangpura, Ahmedabad, Gujarat, 380009, India.
益生菌在炎症性肠病 (IBD) 中表现有前途,通过恢复肠道健康和调节免疫反应. 虽然对性结肠炎 (UC) 有效,但它们在克罗恩氏病中的作用.
科学领域:
- 胃肠道学和免疫学
- 微生物组研究 微生物组研究
- 治疗创新 治疗创新
背景情况:
- 炎症性肠病 (IBD),包括性结肠炎 (UC) 和克罗恩病 (CD),是一种由肠道失调和免疫失调影响的慢性胃肠道疾病.
- 目前的IBD药物治疗面临诸多挑战,包括治疗失败,复发和不良影响,需要替代治疗策略.
- 维持肠道微生物群的稳态对于IBD管理至关重要,因为它在受影响的个体中经常被破坏.
研究的目的:
- 评估益生菌作为炎症性肠病 (IBD) 的辅助疗法的治疗潜力.
- 审查关于益生菌在性结肠炎 (UC) 和克罗恩病 (CD) 中有效性的证据.
- 探索IBD益生菌开发的未来方向,包括精密益生菌.
主要方法:
- 对IBD中益生菌干预的现有临床研究进行系统审查和综合.
- 分析数据,比较益生菌与安慰剂和常规治疗 (如梅萨拉) 的疗效.
- 检查有关特定益生菌菌株和配方的证据 (例如,大肠杆菌尼斯尔1917年,VSL#3).
主要成果:
- 益生菌在诱导和维持UC缓解方面表现出有效性,与传统治疗相比,优于安慰剂.
- 在CD中益生菌疗效的证据是不一致的,在研究中得到的结果是混合的或不确定的.
- 特定的益生菌菌株和配方在调节免疫反应,恢复微生物平衡和保持粘膜完整性方面显示出好处.
结论:
- 益生菌是一种有前途的UC辅助疗法,支持肠道微生物组恒温和免疫调节.
- 需要进一步的大规模,精心设计的研究来确定益生菌在克罗恩病中的疗效.
- 基因工程的进步,包括CRISPR/Cas9,为开发具有增强IBD诊断和治疗能力的精密益生菌铺平了道路.
更多相关视频
07:10Author Spotlight: Development and Application of a Canine IBD Gut-on-a-Chip Model for 3D Intestinal Morphogenesis Studies
Published on: February 9, 2024
09:31Effects of Taste Signaling Protein Abolishment on Gut Inflammation in an Inflammatory Bowel Disease Mouse Model
Published on: November 9, 2018
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
